Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about SVB Leerink
Recent news which mentions SVB Leerink
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today
January 18, 2023
Tickers
GSK
JNJ
MRNA
PFE
Tags
Biotech
Reiteration
Market News
From
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
SVB Leerink
BIIB
ESALY
From
Benzinga
Moderna Rallies After Q4 Earnings: What 2 Analysts Have To Say About COVID-19 Stock
February 24, 2022
Tickers
MRNA
Tags
Mani Foroohar
Earnings
Benzinga
From
Benzinga
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
December 23, 2021
Tickers
MRK
PFE
Tags
News
Benzinga
Geoff Meacham
From
Benzinga
Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst
November 23, 2021
Tickers
AZN
BNTX
GSK
JNJ
Tags
SVB Leerink
BNTX
MRNA
From
Benzinga
Why InflaRx Shares Are Ripping Higher Thursday
October 28, 2021
Tickers
IFRX
Tags
SVB Leerink
Movers
Steven Seedhouse
From
Benzinga
Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism
September 27, 2021
Tickers
GSK
SNY
Tags
Upgrades
Market News
Health Care
From
Benzinga
Why Did SVB Leerink Initiate Humana With Outperform?
September 27, 2021
Tickers
HUM
UNH
Tags
UNH
HUM
Whit Mayo
From
Benzinga
What 3 FibroGen Analysts Are Expecting From Thursday's Roxadustat Adcom Verdict
July 14, 2021
Tickers
AZN
FGEN
Tags
Biotech
Market News
Reiteration
From
Benzinga
Biohaven Rallies On Preliminary Nurtec Revenue Numbers: What Investors Need To Know
July 07, 2021
Tickers
BHVN
Tags
Retail Sales
Press Releases
Analyst Color
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.